Is Glucosamine Bad for You? Side Effects and Who Should Ask First

A woman in a yellow swim cap swims a length of a sunlit outdoor pool.
In this article
  1. What are the side effects of glucosamine?
  2. Who should not take glucosamine, or should ask first?
  3. Glucosamine and warfarin
  4. Glucosamine and shellfish allergy
  5. Glucosamine and diabetes: does it raise blood sugar?
  6. Is glucosamine safe for the liver and kidneys?
  7. What not to mix with glucosamine
  8. Why do doctors not recommend glucosamine?
  9. Is it safe to take glucosamine every day, and for how long?
  10. What we don't know
  11. Frequently asked questions

No, glucosamine is not bad for you. For most adults it is one of the better-tolerated supplements: across twenty randomised trials, side effects were no more frequent on glucosamine than on placebo, and in the largest trial adverse events were mild and evenly spread.1, 6 The better question is who should ask first: people on warfarin, after more than 40 reports of clotting times rising; shellfish allergy with a shell-derived product; diabetes, where the advice is to monitor, not avoid; glaucoma; and pregnancy, where there are no trials.2, 3, 4 Kidney and liver damage, atrial fibrillation and dementia do not hold up against the evidence.

Sources checked on 30 October 2026.

  • Side effects in trials: no more frequent than on placebo across 20 trials
  • Kidneys and liver: no harm on blood or urine measures in trials; isolated liver case reports, none proving cause

What are the side effects of glucosamine?

Mild and uncommon. The Cochrane review of 20 randomised trials in 2,570 people found adverse reactions on glucosamine 0.97 times as likely as on placebo, and the three-year trial of glucosamine sulphate recorded no difference in safety or in reasons for dropping out.1, 5 In GAIT, the largest trial, adverse events were mild, infrequent and evenly spread across all groups.6

Who should not take glucosamine, or should ask first?

Situation What is known What to do
Warfarin or another coumarin anticoagulant More than 40 case reports of a raised INR after starting glucosamine, mostly symptomless, some with bleeding; the INR usually fell on stopping2, 3 Tell your GP or anticoagulant clinic before starting; expect extra INR checks
Shellfish allergy 15 adults with confirmed shrimp allergy tolerated 1,500 mg of shell-derived glucosamine in a blinded challenge; 263 of 366 Australian adverse-reaction reports were hypersensitivity reactions, and whether those people had a shellfish allergy is not known; UK labels still warn7, 21 Choose a vegan glucosamine, made without shellfish
Type 2 diabetes HbA1c unchanged over 90 days in a randomised trial; fasting glucose unchanged in trials up to three years8, 9 Take it; check your readings in the first few weeks
Glaucoma or raised eye pressure A 2013 case series of raised eye pressure, reversible on stopping; in a three-month double-masked trial of 88 people with osteoarthritis, a rise of 2 mmHg or more occurred in 34.1% on glucosamine sulphate against 12.5% on placebo (the authors declare no conflict of interest; funding not stated on PubMed), while a six-month randomised trial of 42 people, comparing 1,500 mg of crystalline glucosamine sulphate added to usual treatment against usual treatment alone, with no placebo, found no change in eye pressure (funding not stated on PubMed)4, 22, 23 Mention it to your optometrist or eye clinic
Pregnancy and breastfeeding No trials; one comparative cohort followed 54 women who took glucosamine in pregnancy and found no major malformations, too few to rule out a risk24 Leave it until afterwards
Thyroid condition or levothyroxine Some joint products include seaweed; some seaweeds are very high in iodine, and high intakes over time can affect the thyroid10, 18 Ask your GP if the label lists bladderwrack or kelp

Glucosamine and warfarin

In 2011 the European Food Safety Authority reviewed more than 40 reports to drug-monitoring agencies of the INR, the measure of warfarin's effect, rising after people on coumarin anticoagulants started glucosamine. Most rises caused no symptoms; some caused bleeding, and one left a patient in a persistent vegetative state. In most cases the INR fell back when glucosamine was stopped, which is what makes the link convincing; the mechanism is unknown.2, 3 The UK prescribing information for warfarin, revised in May 2026, says: "Increased INR has been reported in patients taking glucosamine and warfarin. This combination is not recommended."25 The same document adds: "Patients treated with oral vitamin K antagonists should therefore be closely monitored at the time of initiation or termination of glucosamine therapy."25 The evidence is case reports: no controlled study has given glucosamine to people taking warfarin, and EFSA found the case reports insufficient to assess the level of risk, so how often the INR rises is not known.2 A study that measured markers of cytochrome P450 enzyme activity in 12 healthy volunteers, without giving warfarin, found no significant effect of glucosamine on those markers, which leaves the mechanism open (non-US government research support, funder not named on PubMed).26 If you take warfarin or acenocoumarol, tell your GP or anticoagulant clinic before starting glucosamine. The newer anticoagulants are not the subject of the reports; tell your prescriber anyway.

Glucosamine and shellfish allergy

Most glucosamine is made from the shells of prawns, crabs and lobsters, and UK labels carry a crustacean warning. When 15 adults with shrimp allergy confirmed by skin and blood tests took 1,500 mg of shrimp-derived glucosamine in a double-blind challenge, none reacted.7 The other side of the evidence is spontaneous reports: of 366 adverse-reaction reports for glucosamine and chondroitin products sent to the Australian regulator between 2000 and 2011, 263 were hypersensitivity reactions, 43 of them severe, and it is not clear from the reports whether the people had a shellfish allergy, so they cannot show how often reactions happen (no competing interests declared; funding not stated on PubMed).21 That is one small study on one side and reports with no denominator on the other, and a label warning is a label warning, so the practical answer is a vegan glucosamine: the same molecule, made from plant or microbial sources without shellfish. Some vegan blends add seaweed, and some seaweeds are very high in iodine, so anyone with a thyroid condition or on levothyroxine should check with their GP first;18 the warfarin rule applies to any glucosamine, whatever else is in the capsule.

Glucosamine and diabetes: does it raise blood sugar?

Not at supplement doses, in the trials. The worry came from animal infusions and from cell studies run at concentrations 100 to 200 times the tissue levels oral glucosamine produces.11 In people, a 90-day randomised trial in type 2 diabetes found no change in HbA1c, and a review of the long-term trials, including people with diabetes and pre-diabetes, concluded there is no effect on fasting glucose at any oral dose.8, 9 A few small studies in people with impaired glucose tolerance saw a dip in insulin sensitivity, so take it and check your readings in the first few weeks.

Is glucosamine safe for the liver and kidneys?

At normal doses there is no evidence of harm to either. Trials running up to three years and a safety review of data from 3,063 participants found no adverse effects on blood, urine or stool measures.5, 11 Beyond that there are isolated case reports of liver injury, which the US liver-injury database LiverTox judges must be very rare if glucosamine causes it at all.12 A case report cannot show that the supplement caused what happened. If you have chronic kidney disease, ask your renal team.

What not to mix with glucosamine

Warfarin and the other coumarins, as above. Nothing else is established. Chondroitin, MSM and collagen have no known harmful interaction with glucosamine, though chondroitin lowered blood glucosamine in one study;6 collagen and glucosamine together covers that pairing.

Why do doctors not recommend glucosamine?

Because the 2022 NICE guideline judged the evidence inconsistent, with the largest benefits in smaller, lower-quality studies.20 The 2010 network meta-analysis of ten large trials in 3,803 people found an average effect on pain too small to be clinically relevant, while the Cochrane review found that glucosamine sulphate, in the preparation most of the positive trials used at 1,500 mg a day, improved pain and function against placebo, and individual response varies more than the averages show.1, 14 UK guidance does not recommend glucosamine on the NHS and GPs no longer prescribe it, yet glucosamine has been licensed in the UK as a medicine for knee osteoarthritis symptoms, and the guidance gives no safety reason.15, 17, 20 The Wellgard joint health guide sets out the trials.

Is it safe to take glucosamine every day, and for how long?

Yes, daily is how it was tested: every trial dosed it every day, and the longest ran for three years with no safety difference from placebo.5 Beyond three years there is only cohort data, and UK Biobank's regular users had lower, not higher, death rates, including from cardiovascular disease.13 The fair test is three months daily, then stop if nothing has changed.

What we don't know

  • Use in pregnancy and in kidney disease, where there are no trials.
  • Heart rhythm in people: the atrial fibrillation signal so far comes from mice.19
  • Eye pressure: one trial found a rise and one did not, and in UK Biobank glucosamine use was associated with higher eye pressure in an observational analysis, which cannot show cause.27

Frequently asked questions

Does the NHS recommend glucosamine?

No. GPs no longer prescribe glucosamine or chondroitin on the NHS, and NICE advises against offering glucosamine.15, 20

What are the negative side effects of glucosamine chondroitin?

The same as glucosamine alone, including the warfarin caution, since case reports include combination products; in GAIT the combination's adverse events matched placebo.3, 6

Does glucosamine cause atrial fibrillation or palpitations?

The concern comes from animal work: in a 2025 mouse study, high-dose glucosamine for six weeks made atrial fibrillation easier to trigger.19 In UK Biobank, regular users had fewer cardiovascular deaths, not more, an observational finding and not a benefit claim.13

Does glucosamine cause dementia?

No. In about 290,000 UK Biobank participants followed for about ten years, habitual glucosamine use was not associated with dementia.16

Sources

  1. Towheed TE, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database of Systematic Reviews, 2005. Cochrane systematic review, 20 trials, 2,570 people; one author held patents on glucosamine-type compounds. PubMed 15846645.
  2. EFSA Panel on Dietetic Products, Nutrition and Allergies. Safety of glucosamine for patients on coumarin anticoagulants. EFSA Journal, 2011. Agency statement reviewing more than 40 case reports. PubMed 42015979.
  3. Knudsen JF, Sokol GH. Potential glucosamine-warfarin interaction: case report and review. Pharmacotherapy, 2008. Case report with a review of US and WHO adverse-event reports; funding not stated on PubMed. PubMed 18363538.
  4. Murphy RK, et al. Oral glucosamine supplements as a possible ocular hypertensive agent. JAMA Ophthalmology, 2013. Case series published as a letter; size not given on PubMed. PubMed 23702812.
  5. Reginster JY, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression. Lancet, 2001. Randomised placebo-controlled trial, 212 people, 3 years; funding not stated on PubMed. PubMed 11214126.
  6. Clegg DO, et al. Glucosamine, chondroitin sulfate, or both for painful knee osteoarthritis (GAIT). New England Journal of Medicine, 2006. Randomised placebo-controlled trial, 1,583 people, 24 weeks; NIH-funded. PubMed 16495392. Jackson CG, et al. (GAIT pharmacokinetic study), 2010, Osteoarthritis and Cartilage. Pharmacokinetic study within GAIT, 57 people; NIH-funded. PubMed 19912983.
  7. Villacis J, et al. Do shrimp-allergic individuals tolerate shrimp-derived glucosamine? Clinical and Experimental Allergy, 2006. Randomised double-blind food challenge, 15 people; NIH-funded. PubMed 17083356.
  8. Scroggie DA, et al. Glucosamine-chondroitin and HbA1c in type 2 diabetes. Archives of Internal Medicine, 2003. Randomised placebo-controlled trial in people with type 2 diabetes, 90 days; size not given in the abstract; US government funding. PubMed 12860582.
  9. Simon RR, et al. Oral glucosamine and glucose metabolism: a review. Diabetes/Metabolism Research and Reviews, 2011. Narrative review; funding not stated on PubMed. PubMed 21218504.
  10. NHS. Iodine: vitamins and minerals. Page last reviewed 3 August 2020 (review overdue). nhs.uk/conditions/vitamins-and-minerals/iodine.
  11. Anderson JW, et al. Glucosamine effects in humans: a review. Food and Chemical Toxicology, 2005. Review of animal data and human trials in 3,063 people; funding not stated on PubMed. PubMed 15621331.
  12. LiverTox. Glucosamine, 2012. Reference database entry, US National Institute of Diabetes and Digestive and Kidney Diseases. PubMed 31643282.
  13. Li ZH, et al. Regular glucosamine use and mortality: a prospective cohort study. Annals of the Rheumatic Diseases, 2020. Prospective cohort, 495,077 UK Biobank adults, median 8.9 years; public research funding; no conflicts declared. PubMed 32253185.
  14. Wandel S, et al. Glucosamine, chondroitin or placebo in hip or knee osteoarthritis: network meta-analysis. BMJ, 2010. Network meta-analysis, 10 trials, 3,803 people; Medical Research Council funding. PubMed 20847017.
  15. NHS. Osteoarthritis: treatment. Page last reviewed 20 March 2023 (review overdue). nhs.uk/conditions/osteoarthritis/treatment.
  16. Ai B, et al. Glucosamine and dementia or Parkinson's disease: a prospective cohort study. Journals of Gerontology Series A, 2024. Prospective cohort, about 290,000 UK Biobank adults, median 9 to 11 years; funding not stated on PubMed. PubMed 37158699.
  17. MHRA. Change in the classification of certain glucosamine products. News story, 5 September 2018. gov.uk.
  18. Teas J, et al. Variability of iodine content in common commercially available edible seaweeds. Thyroid, 2004. Laboratory analysis of 12 seaweed species; public research support. PubMed 15588380.
  19. Qin X, et al. Long-term glucosamine and atrial fibrillation susceptibility in mice. Life Sciences, 2025. Mouse study; no competing interests declared. PubMed 39788416.
  20. NICE. Osteoarthritis in over 16s: diagnosis and management (NG226). Clinical guideline, 2022. nice.org.uk.
  21. Hoban C, et al. Hypersensitive adverse drug reactions to glucosamine and chondroitin preparations in Australia between 2000 and 2011. Postgraduate Medical Journal, 2020. Analysis of 366 spontaneous adverse-reaction reports sent to the Australian regulator, 2000 to 2011; no competing interests declared; funding not stated on PubMed. PubMed 31597786.
  22. Esfandiari H, et al. Effect of glucosamine on intraocular pressure: a randomized clinical trial. Eye, 2017. Double-masked randomised placebo-controlled trial, 88 people with osteoarthritis, 3 months, glucosamine sulphate (dose not given in the abstract); the authors declare no conflict of interest; funding not stated on PubMed. PubMed 27768119.
  23. Yuenyongviwat V, et al. Effect of glucosamine sulfate on intraocular pressure in patients with knee osteoarthritis: a prospective randomized controlled trial. Journal Français d'Ophtalmologie, 2019. Prospective randomised trial, 42 people with knee osteoarthritis, 6 months, crystalline glucosamine sulphate 1,500 mg once daily added to usual treatment against usual treatment alone, no placebo; funding not stated on PubMed. PubMed 31104873.
  24. Sivojelezova A, et al. Glucosamine use in pregnancy: an evaluation of pregnancy outcome. Journal of Women's Health, 2007. Comparative cohort, 54 women who took glucosamine in pregnancy (34 during organogenesis) matched with women exposed to agents not known to harm a pregnancy; 50 live births, no major malformations; non-US government research support, funder not named on PubMed. PubMed 17439379.
  25. Warfarin 0.5 mg tablets (Marevan), Summary of Product Characteristics, section 4.5. Electronic medicines compendium; date of revision of the text 11 May 2026. medicines.org.uk.
  26. Rosenborg S, et al. Clinically significant CYP2C inhibition by noscapine but not by glucosamine. Clinical Pharmacology and Therapeutics, 2010. Controlled clinical study of cytochrome P450 activity markers, 12 healthy volunteers, separate treatment periods, warfarin not given; non-US government research support, funder not named on PubMed. PubMed 20668444.
  27. Lehrer S, et al. Effect of glucosamine on intraocular pressure and risk of developing glaucoma. Journal of Glaucoma, 2024. Observational analysis of UK Biobank, MedWatch and FinnGen; NIH-funded; the authors declare no conflict of interest. PubMed 38031296.

Spotted something out of date? Email support@wellgard.co.uk with the page address and the sentence.

This article is general information, not medical advice. Joint pain with swelling or heat, or pain after an injury, needs a GP, and if you take warfarin or another anticoagulant, have diabetes or are pregnant, speak to your GP or pharmacist before starting glucosamine.